PopVax is an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using computational protein design. Our first vaccine is a next-generation COVID-19 booster which will enter a first-in-human Phase I clinical trial in the U.S. early next year – this vaccine is intended to broaden protection against both current and predicted future SARS-CoV-2 variants, reducing the possibility of a new mutation in the virus suddenly causing another massive wave of infection. We are now a team of 70+ across our computational design, machine learning, molecular & cell biology, immunology, mRNA delivery, analytical method development, GMP production, quality, and regulatory teams, all of which are hiring. Our experimental work is based at the RNA Foundry, PopVax’s integrated R&D and GMP-capable clinical dose production facility in Hyderabad. Our work to date has been funded primarily via project agreements with the Bill & Melinda Gates Foundation and Vitalik Buterin's public health & biosecurity organization Balvi. Over the next decade, our mission is to develop and distribute vaccines that save one million lives each year across the world that would otherwise be lost to infectious diseases.
External link for PopVax
Hyderabad, IN
We're developing an n=1 cancer immunotherapy using generative AI to extend the life of Yash Bindal, a 33-year-old pancreatic cancer patient with an 18-month-old daughter.
I never met my grandfather. He died of pancreatic cancer when my father was just 19. Today, Yash Bindal, 33, father to 18-month-old Maya, faces the same fate. PopVax is using AI to make him a personalized generative medicine to extend his life. https://lnkd.in/gr9esKtT
Please re-send any emails you sent to us at PopVax last night or this morning before 8:15am IST.
We at PopVax had an unfortunate email outage from 3am to 8am IST this morning during which emails sent to our popvax.com domain were not delivered. If you emailed anyone at PopVax last night or this morning before 8:15am IST, please re-send your email now.
This is an exciting opportunity to work closely with our founder Soham Sankaran and our VP of Protein Design Dr Tushar Ranjan Moharana at the frontier of protein design for new vaccines and therapeutics!
🚀 Join PopVax as a Junior Scientist / Scientist – Protein & RNA Design (Hyderabad)! 🚀 Are you passionate about computational biology and mRNA vaccine innovation? PopVax, a next‑gen biotech pioneering mRNA therapeutics, is seeking a driven Junior Scientist or Scientist to join our Computational Design Team in Hyderabad jobs.popvax.com . 🔬 What You’ll Tackle: Design next‑gen protein & RNA antigens for broad immunity Prototype new computational vaccine candidates Analyze non‑clinical & clinical data to inform design Stay ahead of the curve in vaccine design literature jobs.popvax.com 🎓 What We’re Looking For: M.S. in Bioinformatics (or related) + structural bioinformatics experience (for Junior Scientists); PhD or 4+ years industry experience for Scientist Skills in protein modeling, docking, molecular dynamics, NGS data analysis Proficiency in Python/R, Linux, bioinformatics tools (e.g., BLAST, MSA) Strong immunology basics + a “yes I can” mindset jobs.popvax.com 💡 Perks & Culture: Join a visionary team under an experienced VP of Protein Design Hands‑on opportunities in a mission‑driven, fast‑growing startup 📬 Apply now: https://lnkd.in/gNQtGVgW Note: Those who have applied in the last 6 months will be automatically considered.
PopVax reposted this
Exciting opportunity to work at the frontier of protein design for novel vaccines and therapeutics with us at PopVax! The protein & RNA design teams led by Dr Tushar Ranjan Moharana collaborate closely with me personally.
Vice President - Protein Design, Head of Bioinformatics (Principal Scientist), PopVax Pvt. Ltd.
🚀 Join PopVax as a Junior Scientist / Scientist – Protein & RNA Design (Hyderabad)! 🚀 Are you passionate about computational biology and mRNA vaccine innovation? PopVax, a next‑gen biotech pioneering mRNA therapeutics, is seeking a driven Junior Scientist or Scientist to join our Computational Design Team in Hyderabad jobs.popvax.com . 🔬 What You’ll Tackle: Design next‑gen protein & RNA antigens for broad immunity Prototype new computational vaccine candidates Analyze non‑clinical & clinical data to inform design Stay ahead of the curve in vaccine design literature jobs.popvax.com 🎓 What We’re Looking For: M.S. in Bioinformatics (or related) + structural bioinformatics experience (for Junior Scientists); PhD or 4+ years industry experience for Scientist Skills in protein modeling, docking, molecular dynamics, NGS data analysis Proficiency in Python/R, Linux, bioinformatics tools (e.g., BLAST, MSA) Strong immunology basics + a “yes I can” mindset jobs.popvax.com 💡 Perks & Culture: Join a visionary team under an experienced VP of Protein Design Hands‑on opportunities in a mission‑driven, fast‑growing startup 📬 Apply now: https://lnkd.in/gNQtGVgW Note: Those who have applied in the last 6 months will be automatically considered.
PopVax reposted this
PopVax is honoured to be the subject of Aaryaman Vir Shah's new piece at Tigerfeathers – he's done an excellent job of explaining what we do for a non-biotech audience, as well as outlining the immense opportunity we see in doing cutting-edge biotech R&D in India. More on this soon!
Humanity is building digital AI gods and expanding to the stars. The world is changing, but the most important thing has remained unchanged: biology, the machinery of life. However, recent advances in technology are creating the conditions for us to rewrite the rules of life by applying the same neural network architectures that have revolutionized other fields. The next decades will be marked by radical breakthroughs in our ability to extend, improve, and alter the idea of life itself. India has a unique opportunity to lead this charge. In this essay, we dive deep into this new field by profiling one of the most exciting and revolutionary companies in the whole country - PopVax, led by Soham Sankaran. Some of the things you will learn in this piece include: - How AI is reshaping our ability to understand and design biology - Why mRNA is more than just a COVID-era blip - What building an mRNA therapy looks like, from start to finish - Why India has a tangible advantage in the biotech arena We hope you enjoy it. Only on Tigerfeathers 🐯🪶 https://lnkd.in/dTqbAfCr
LinkedIn is better on the app
Don’t have the app? Get it in the Microsoft Store.
Open the app